PTGX - Protagonist Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PTGX is currently covered by 11 analysts with an average price target of $99.56. This is a potential upside of $18.07 (22.17%) from yesterday's end of day stock price of $81.49.

Protagonist Therapeutics's activity chart (see below) currently has 142 price targets and 139 ratings on display. The stock rating distribution of PTGX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 90.58% with an average time for these price targets to be met of 514.4 days.

Highest price target for PTGX is $117, Lowest price target is $68, average price target is $97.89.

Most recent stock forecast was given by DOUGLAS TSAO from HC WAINWRIGHT on 30-Jan-2026. First documented stock forecast 06-Sep-2016.

Currently out of the existing stock ratings of PTGX, 40 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 06-Sep-2016

$117

$35.51 (43.58%)

$80

16 days ago
(30-Jan-2026)

34/35 (97.14%)

$35.2 (43.03%)

286

Buy Since 09-Sep-2024

$110

$28.51 (34.99%)

$88

1 months 10 days ago
(05-Jan-2026)

5/6 (83.33%)

$25.82 (30.67%)

210

Buy Since 05-Dec-2024

$108

$26.51 (32.53%)

$88

1 months 29 days ago
(17-Dec-2025)

4/5 (80%)

$18.66 (20.89%)

136

Buy Since 17-Jun-2025

$115

$33.51 (41.12%)

$96

2 months 7 days ago
(08-Dec-2025)

1/3 (33.33%)

$24.75 (27.42%)

115

Buy Since 07-Mar-2023

$93

$11.51 (14.12%)

$81

2 months 26 days ago
(20-Nov-2025)

11/11 (100%)

$8.8 (10.45%)

108

Show more analysts

Please expand the browser size to see the chart

What is PTGX (Protagonist Therapeutics) average time for price targets to be met?

On average it took 514.4 days on average for the stock forecasts to be realized with a an average price target met ratio 90.58

Which analyst has the current highest performing score on PTGX (Protagonist Therapeutics) with a proven track record?

YASMEEN RAHIMI

Which analyst has the most public recommendations on PTGX (Protagonist Therapeutics)?

Yasmeen Rahimi works at PIPER SANDLER and has 1 price targets and 2 ratings on PTGX

Which analyst is the currently most bullish on PTGX (Protagonist Therapeutics)?

Tim Chiang with highest potential upside - $47.4

Which analyst is the currently most reserved on PTGX (Protagonist Therapeutics)?

Adam Walsh with lowest potential downside - -$64.49

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?